Adage Capital Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-296,543
Closed -$15.1M 979
2024
Q4
$15.1M Buy
+296,543
New +$14.6M 0.03% 503
2024
Q3
Sell
-203,427
Closed -$9.8M 955
2024
Q2
$9.8M Buy
+203,427
New +$9.02M 0.02% 612
2023
Q2
Sell
-335,859
Closed -$20.7M 948
2023
Q1
$20.7M Buy
+335,859
New +$20.2M 0.05% 404
2021
Q3
Sell
-85,000
Closed -$7.93M 1083
2021
Q2
$7.93M Buy
+85,000
New +$8.24M 0.02% 754
2021
Q1
Sell
-175,000
Closed -$15.3M 1041
2020
Q4
$15.3M Buy
175,000
+100,000
+133% +$7.06M 0.03% 495
2020
Q3
$5.18M Sell
75,000
-225,000
-75% -$14.5M 0.01% 632
2020
Q2
$14.5M Buy
+300,000
New +$14.3M 0.04% 467

Other funds holding NARI

Adage Capital Partners's NARI Position: Q1 2025 in Review

Adage Capital Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 296,543 shares — an estimated $15.1M sold.

Adage Capital Partners first reported a position in NARI in Q2 2020 and held it in 7 quarters. The position peaked at $20.7M in Q1 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Adage Capital Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Adage Capital Partners sold 296,543 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $15.1M.
  • Adage Capital Partners first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Adage Capital Partners's Inari Medical, Inc. Common Stock position peaked at $20.7M in Q1 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.